Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

ALT – Altimmune Inc

Name : Altimmune, Inc.
Sector : Healthcare
Industry: Biotechnology
Mark. Cap: $0.0000
EPSttm :
finviz dynamic chart for ALT
[iframe https://s.tradingview.com/embed-widget/symbol-info/?locale=in&symbol=ALT #%7B%22symbol%22%3A%22A%22%2C%22width%22%3A%22100%25%22%2C%22colorTheme%22%3A%22light%22%2C%22isTransparent%22%3Atrue%2C%22height%22%3A203%2C%22utm_source%22%3A%22themarketstracker.com%22%2C%22utm_medium%22%3A%22widget_new%22%2C%22utm_campaign%22%3A%22symbol-info%22%7D 900 250 ]
[iframe https://api.stockdio.com/visualization/financial/charts/v1/PricesChange?app-key=F086EEE750E14D8D8A456DB88B2D6D8C&symbol=ALT &conditionalVolume=false&allowPeriodChange=false&tooltipsStyle=None&palette=Financial-Light&showBorderAndTitle=false 300 200 ]

Float Short %

35.01

Margin Of Safety %

Put/Call OI Ratio

0.28

EPS Next Q Diff

-0.06

EPS Last/This Y

0.11

EPS This/Next Y

-0.23

Price

3.61

Target Price

18.89

Analyst Recom

1.6

Performance Q

-30.17

Relative Volume

0.32

Beta

-0.01

Ticker: ALT




21 items of 1

DateSymbolLastP/C OIP/C VolTotal OI
2025-07-04ALT4.750.380.37253656
2025-07-07ALT4.440.320.16199083
2025-07-08ALT4.580.310.49204637
2025-07-09ALT4.730.310.22206998
2025-07-10ALT4.390.300.39210267
2025-07-11ALT4.140.310.74212999
2025-07-14ALT4.250.310.57201183
2025-07-15ALT4.180.310.84203381
2025-07-16ALT4.180.310.30205270
2025-07-17ALT4.050.310.35207634
2025-07-18ALT4.090.311.86208765
2025-07-21ALT4.050.250.11165783
2025-07-22ALT4.210.240.21169821
2025-07-23ALT4.280.240.15172215
2025-07-24ALT4.10.230.28175689
2025-07-25ALT4.070.230.17176080
2025-07-28ALT4.030.230.59169944
2025-07-29ALT3.830.240.28174502
2025-07-30ALT3.650.242.13176286
2025-07-31ALT3.690.280.20182597
2025-08-01ALT3.610.280.27182624
DateSymbolLastP/C OIP/C VolTotal OI
21 items Current Page1 of 1




21 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2025-07-04ALT4.7614.1-16.9-1.27
2025-07-07ALT4.4314.1-9.4-1.27
2025-07-08ALT4.5814.1-28.5-1.27
2025-07-09ALT4.7414.1-28.5-1.27
2025-07-10ALT4.4014.1-8.8-1.27
2025-07-11ALT4.1414.11.5-1.27
2025-07-14ALT4.2514.1-27.1-1.27
2025-07-15ALT4.1814.1-18.2-1.27
2025-07-16ALT4.1814.1-21.9-1.27
2025-07-17ALT4.0514.1-15.9-1.27
2025-07-18ALT4.0914.1-23.6-1.27
2025-07-21ALT4.0614.1-20.6-1.27
2025-07-22ALT4.2114.1-30.0-1.27
2025-07-23ALT4.2914.1-26.1-1.27
2025-07-24ALT4.1114.1-13.4-1.27
2025-07-25ALT4.0814.1-20.5-1.27
2025-07-28ALT4.0314.1-19.4-1.27
2025-07-29ALT3.8314.1-11.4-1.27
2025-07-30ALT3.6514.1-11.6-1.27
2025-07-31ALT3.6914.1-24.7-1.27
2025-08-01ALT3.618.4-17.1-1.23
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
21 items Current Page1 of 1




21 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2025-07-04ALT1.32-5.6530.40
2025-07-07ALT1.32-5.6530.40
2025-07-08ALT1.32-5.6530.40
2025-07-09ALT1.32-5.6530.40
2025-07-10ALT1.32-5.6530.40
2025-07-11ALT1.32-5.6538.85
2025-07-14ALT1.32-5.4938.85
2025-07-15ALT1.32-5.4938.85
2025-07-16ALT1.32-5.4938.85
2025-07-17ALT1.32-5.4938.85
2025-07-18ALT1.32-5.4938.85
2025-07-21ALT1.32-5.3938.85
2025-07-22ALT1.32-5.3938.85
2025-07-23ALT1.32-5.3938.85
2025-07-24ALT1.32-5.3938.85
2025-07-25ALT1.32-5.3935.01
2025-07-28ALT1.32-5.2835.01
2025-07-29ALT1.32-5.2835.01
2025-07-30ALT1.32-5.2835.01
2025-07-31ALT1.32-5.2835.01
2025-08-01ALT1.32-5.2835.01
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
21 items Current Page1 of 1

[iframe https://widget.finnhub.io/widgets/historical-eps?symbol=ALT 589 360 ]

Last Quarter Act. EPS

-0.26

Avg. EPS Est. Current Quarter

-0.3

Avg. EPS Est. Next Quarter

-0.32

Insider Transactions

1.32

Institutional Transactions

-5.28

Beta

-0.01

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

24

Growth Score

29

Sentiment Score

21

Actual DrawDown %

87.9

Max Drawdown 5-Year %

-92.4

Target Price

18.89

P/E

Forward P/E

PEG

P/S

14639.58

P/B

1.98

P/Free Cash Flow

EPS

-1.25

Average EPS Est. Cur. Y​

-1.23

EPS Next Y. (Est.)

-1.46

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-451200

Relative Volume

0.32

Return on Equity vs Sector %

-87.2

Return on Equity vs Industry %

-68.6

EPS 1 7Days Diff

EPS 1 30Days Diff

0.03

EBIT Estimation

-17.1
[iframe https://widget.finnhub.io/widgets/recommendation?symbol=ALT 589 450 ]
[iframe https://widget.finnhub.io/widgets/eps-estimate?symbol=ALT 589 450 ]
Altimmune, Inc.
Sector: Healthcare
Industry: Biotechnology
Employees: 59
Altimmune, Inc., a clinical stage biopharmaceutical company, focuses on developing treatments for obesity, metabolic, and liver diseases. Its lead product candidate is pemvidutide, a GLP-1/glucagon dual receptor agonist, which is in Phase 3 trial for the treatment of obesity and metabolic associated steatohepatitis. The company was founded in 1997 and is headquartered in Gaithersburg, Maryland.
stock quote shares ALT – Altimmune Inc Stock Price stock today
news today ALT – Altimmune Inc stock forecast ,stock prediction 2023 2024 2025
marketwatch ALT – Altimmune Inc yahoo finance google finance
stock history ALT – Altimmune Inc invest stock market
stock prices ALT premarket after hours
ticker ALT fair value insiders trading

ALT – Altimmune, Inc.

Altimmune, Inc.
ALT
$3.61
Name : Altimmune, Inc.
Sector : Healthcare
Industry: Biotechnology
Mark. Cap: $292,796,256.00
EPSttm : -1.26
finviz dynamic chart for ALT
Altimmune, Inc.
$3.61
2.17%
$0.08

Float Short %

35.01

Margin Of Safety %

Put/Call OI Ratio

0.28

EPS Next Q Diff

-0.06

EPS Last/This Y

0.11

EPS This/Next Y

-0.23

Price

3.61

Target Price

18.89

Analyst Recom

1.6

Performance Q

-30.17

Relative Volume

0.32

Beta

-0.01

Ticker: ALT




21 items of 1

DateSymbolLastP/C OIP/C VolTotal OI
2025-07-04ALT4.750.380.37253656
2025-07-07ALT4.440.320.16199083
2025-07-08ALT4.580.310.49204637
2025-07-09ALT4.730.310.22206998
2025-07-10ALT4.390.300.39210267
2025-07-11ALT4.140.310.74212999
2025-07-14ALT4.250.310.57201183
2025-07-15ALT4.180.310.84203381
2025-07-16ALT4.180.310.30205270
2025-07-17ALT4.050.310.35207634
2025-07-18ALT4.090.311.86208765
2025-07-21ALT4.050.250.11165783
2025-07-22ALT4.210.240.21169821
2025-07-23ALT4.280.240.15172215
2025-07-24ALT4.10.230.28175689
2025-07-25ALT4.070.230.17176080
2025-07-28ALT4.030.230.59169944
2025-07-29ALT3.830.240.28174502
2025-07-30ALT3.650.242.13176286
2025-07-31ALT3.690.280.20182597
2025-08-01ALT3.610.280.27182624
DateSymbolLastP/C OIP/C VolTotal OI
21 items Current Page1 of 1




21 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2025-07-04ALT4.7614.1-16.9-1.27
2025-07-07ALT4.4314.1-9.4-1.27
2025-07-08ALT4.5814.1-28.5-1.27
2025-07-09ALT4.7414.1-28.5-1.27
2025-07-10ALT4.4014.1-8.8-1.27
2025-07-11ALT4.1414.11.5-1.27
2025-07-14ALT4.2514.1-27.1-1.27
2025-07-15ALT4.1814.1-18.2-1.27
2025-07-16ALT4.1814.1-21.9-1.27
2025-07-17ALT4.0514.1-15.9-1.27
2025-07-18ALT4.0914.1-23.6-1.27
2025-07-21ALT4.0614.1-20.6-1.27
2025-07-22ALT4.2114.1-30.0-1.27
2025-07-23ALT4.2914.1-26.1-1.27
2025-07-24ALT4.1114.1-13.4-1.27
2025-07-25ALT4.0814.1-20.5-1.27
2025-07-28ALT4.0314.1-19.4-1.27
2025-07-29ALT3.8314.1-11.4-1.27
2025-07-30ALT3.6514.1-11.6-1.27
2025-07-31ALT3.6914.1-24.7-1.27
2025-08-01ALT3.618.4-17.1-1.23
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
21 items Current Page1 of 1




21 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2025-07-04ALT1.32-5.6530.40
2025-07-07ALT1.32-5.6530.40
2025-07-08ALT1.32-5.6530.40
2025-07-09ALT1.32-5.6530.40
2025-07-10ALT1.32-5.6530.40
2025-07-11ALT1.32-5.6538.85
2025-07-14ALT1.32-5.4938.85
2025-07-15ALT1.32-5.4938.85
2025-07-16ALT1.32-5.4938.85
2025-07-17ALT1.32-5.4938.85
2025-07-18ALT1.32-5.4938.85
2025-07-21ALT1.32-5.3938.85
2025-07-22ALT1.32-5.3938.85
2025-07-23ALT1.32-5.3938.85
2025-07-24ALT1.32-5.3938.85
2025-07-25ALT1.32-5.3935.01
2025-07-28ALT1.32-5.2835.01
2025-07-29ALT1.32-5.2835.01
2025-07-30ALT1.32-5.2835.01
2025-07-31ALT1.32-5.2835.01
2025-08-01ALT1.32-5.2835.01
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
21 items Current Page1 of 1

Last Quarter Act. EPS

-0.26

Avg. EPS Est. Current Quarter

-0.3

Avg. EPS Est. Next Quarter

-0.32

Insider Transactions

1.32

Institutional Transactions

-5.28

Beta

-0.01

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

24

Growth Score

29

Sentiment Score

21

Actual DrawDown %

87.9

Max Drawdown 5-Year %

-92.4

Target Price

18.89

P/E

Forward P/E

PEG

P/S

14639.58

P/B

1.98

P/Free Cash Flow

EPS

-1.25

Average EPS Est. Cur. Y​

-1.23

EPS Next Y. (Est.)

-1.46

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-451200

Relative Volume

0.32

Return on Equity vs Sector %

-87.2

Return on Equity vs Industry %

-68.6

EPS 1 7Days Diff

EPS 1 30Days Diff

0.03

EBIT Estimation

-17.1
Altimmune, Inc.
Sector: Healthcare
Industry: Biotechnology
Employees: 59
Altimmune, Inc., a clinical stage biopharmaceutical company, focuses on developing treatments for obesity, metabolic, and liver diseases. Its lead product candidate is pemvidutide, a GLP-1/glucagon dual receptor agonist, which is in Phase 3 trial for the treatment of obesity and metabolic associated steatohepatitis. The company was founded in 1997 and is headquartered in Gaithersburg, Maryland.
stock quote shares ALT – Altimmune, Inc. Stock Price stock today
news today ALT – Altimmune, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch ALT – Altimmune, Inc. yahoo finance google finance
stock history ALT – Altimmune, Inc. invest stock market
stock prices ALT premarket after hours
ticker ALT fair value insiders trading